4.6 Review

Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications

Sofia Bougioukli et al.

Summary: The study aimed to compare the effects of AAV vectors and LV-TSTA in transducing human MSCs and inducing osteogenesis, demonstrating that LV-TSTA is superior to AAV in transduction and induction of osteogenesis in vitro.

GENE THERAPY (2021)

Article Biotechnology & Applied Microbiology

Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice

Dhwanil A. Dalwadi et al.

Summary: Integration of adeno-associated virus (AAV) into host genomes can lead to hepatocellular carcinoma (HCC), especially when it occurs in oncogenic hotspots. Research has shown that mice exposed to rAAV gene therapy in the context of non-alcoholic fatty liver disease (NAFLD) are more likely to develop HCC, highlighting the potential risk factors associated with rAAV-induced oncogenesis.

MOLECULAR THERAPY (2021)

Article Biotechnology & Applied Microbiology

Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease

Gregory J. Heller et al.

Summary: Neonatal AAV9 gene therapy of GALC significantly improves neuropathology in Twitcher mice, but leads to the development of multiple small focal demyelinating areas in the brain. These lesions are associated with lysosomal alterations, fibrinogen extravasation, and gliotic response.

MOLECULAR THERAPY (2021)

Article Biotechnology & Applied Microbiology

Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease

Yedda Li et al.

Summary: Replacing AAV2/5 with AAV2/9 significantly improved motor function endpoints in a murine model of Krabbe disease, but led to the development of hepatocellular carcinoma in most treated mice. The study highlights the value of AAV-based combination therapy for Krabbe disease, but also underscores the importance of considering other therapies or comorbidities before proceeding with AAV-mediated gene therapy in human trials.

MOLECULAR THERAPY (2021)

Article Biotechnology & Applied Microbiology

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells

Giang N. Nguyen et al.

Summary: Nine dogs with hemophilia A were treated with AAV gene therapy expressing canine factor VIII and followed for up to 10 years. The therapy corrected the FVIII deficiency in most dogs, with some showing gradual increase in FVIII activity possibly due to clonal expansion of cells. Long-term monitoring for potential genotoxicity is essential for the clinical development of liver-directed AAV gene therapy for hemophilia A.

NATURE BIOTECHNOLOGY (2021)

Review Neurosciences

AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy

Simon J. O'Carroll et al.

Summary: Glial cells play crucial roles in the nervous system and are involved in various diseases, making them potential targets for gene therapy. However, achieving specific targeting for each glial cell type remains a challenge due to technical limitations.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Article Clinical Neurology

Reduction in miR-219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease

Naoko Inamura et al.

Summary: Krabbe disease, caused by the deficiency of lysosomal galactosylceramidase activity, is a demyelinating disease with early-onset cerebral demyelination. The reduced expression of microRNA-219 in KD OLs plays a role in the pathogenesis of the disease, and miR-219 may have therapeutic potential for treating KD OL pathologies.

BRAIN PATHOLOGY (2021)

Article Neurosciences

Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit

Meaghan Van Alstyne et al.

Summary: This study demonstrates that long-term use of AAV9-SMN gene therapy in mice can lead to motor dysfunction and neuronal loss through protein aggregation. Overexpression of SMN interferes with RNA regulation and triggers SMA-like pathogenic events through toxic gain-of-function mechanisms. These findings suggest caution in the long-term safety of treating individuals with SMA with AAV9-SMN.

NATURE NEUROSCIENCE (2021)

Article Neurosciences

Krabbe disease: New hope for an old disease

Allison M. Bradbury et al.

Summary: Krabbe disease is a lysosomal storage disease characterized by demyelination, most commonly in its infantile form. It is caused by a deficiency of the acid hydrolase galactosylceramidase (GALC). Hematopoietic stem cell transplantation can slow the progression of the disease, but more effective treatments are still needed to combat this devastating condition.

NEUROSCIENCE LETTERS (2021)

Article Cell & Tissue Engineering

Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes

Elisabeth Mangiameli et al.

Summary: This study investigated the impact of GALC deficiency and rescue on GLD patients' neural cells, revealing various pathological manifestations and suggesting multiple mechanisms contributing to neural pathology in GLD. It also emphasized the importance of regulated GALC expression for proper human neural commitment and differentiation.

STEM CELL REPORTS (2021)

Article Endocrinology & Metabolism

Rare Saposin A deficiency: Novel variant and psychosine analysis

Laurel Calderwood et al.

MOLECULAR GENETICS AND METABOLISM (2020)

Article Endocrinology & Metabolism

Current Status and Use of Resources of Lysosomal Storage Diseases: Analysis of a Spanish Claims Database

Josep Darba et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)

Article Neurosciences

Inhibition of Piezo1 attenuates demyelination in the central nervous system

Maria Velasco-Estevez et al.

Article Genetics & Heredity

The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease

Adam J. Guenzel et al.

GENETICS IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease

Mirella Belleri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Neurosciences

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease

Sibylle Bechet et al.

JOURNAL OF NEUROSCIENCE (2020)

Article Neurosciences

Cerebrospinal fluid and serum glycosphingolipid biomarkers in canine globoid cell leukodystrophy (Krabbe Disease)

Carley R. Corado et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2020)

Review Medicine, General & Internal

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease

Silvia Paciotti et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, General & Internal

Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression

Camila Para et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Chemistry, Medicinal

Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors

Simona Di Martino et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Medicine, Research & Experimental

Krabbe disease successfully treated via monotherapy of intrathecal gene therapy

Allison M. Bradbury et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Biochemistry & Molecular Biology

In vitroValidation of Chimeric β-Galactosylceramidase Enzymes With Improved Enzymatic Activity and Increased Secretion

Alessandra Ricca et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Medicine, General & Internal

Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches

Alisa A. Shaimardanova et al.

FRONTIERS IN MEDICINE (2020)

Article Genetics & Heredity

Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months

Maria L. Beltran-Quintero et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Editorial Material Clinical Neurology

Newborn screening for Krabbe disease: perceived and current ethical issues

Joseph J. Orsini

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease

Marco Righi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemical Research Methods

Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease

Davide Pellegrini et al.

MOLECULAR & CELLULAR PROTEOMICS (2019)

Article Biotechnology & Applied Microbiology

An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice

Xiufang Pan et al.

HUMAN GENE THERAPY (2019)

Article Neurosciences

Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease

Ambra Del Grosso et al.

NEUROBIOLOGY OF DISEASE (2019)

Article Multidisciplinary Sciences

Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target

Yedda Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Anatomy & Morphology

Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation

Leila Haery et al.

FRONTIERS IN NEUROANATOMY (2019)

Review Biochemical Research Methods

Engineering the AAV capsid to evade immune responses

Christopher Barnes et al.

CURRENT OPINION IN BIOTECHNOLOGY (2019)

Article Veterinary Sciences

Globoid cell leukodystrophy (Krabbe disease) in a Merino sheep

Effie Lee et al.

JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2019)

Article Hematology

Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease

Heather Allewelt et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Review Clinical Neurology

Recent progress and considerations for AAV gene therapies targeting the central nervous system

Erik Allen Lykken et al.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2018)

Article Neurosciences

Inhibitory effect of several sphingolipid metabolites on calcineurin

Yoko Maruyama et al.

NEUROSCIENCE LETTERS (2018)

Review Genetics & Heredity

Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease

Jennifer M. Kwon et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Article Multidisciplinary Sciences

Analysis of age-related changes in psychosine metabolism in the human brain

Michael S. Marshall et al.

PLOS ONE (2018)

Article Multidisciplinary Sciences

The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure

Chris H. Hill et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Structural basis for the activation of acid ceramidase

Ahmad Gebai et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques

Juliette Hordeaux et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Article Multidisciplinary Sciences

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies

Hazem Abdelkarim et al.

SCIENTIFIC REPORTS (2018)

Letter Genetics & Heredity

Serendipitous effects of β-cyclodextrin on murine model of Krabbe disease

Asaka U. Katabuchi et al.

MOLECULAR GENETICS AND METABOLISM REPORTS (2018)

Article Endocrinology & Metabolism

Psychosine, a marker of Krabbe phenotype and treatment effect

M. L. Escolar et al.

MOLECULAR GENETICS AND METABOLISM (2017)

Article Genetics & Heredity

Newborn screening for Krabbe disease in New York State: the first eight years' experience

Joseph J. Orsini et al.

GENETICS IN MEDICINE (2016)

Review Neurosciences

Biochemical, Cell Biological, Pathological, and Therapeutic Aspects of Krabbe's Disease

Je-Seong Won et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2016)

Review Neurosciences

Axonal Pathology in Krabbe's Disease: The Cytoskeleton as an Emerging Therapeutic Target

Joana Nogueira-Rodrigues et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2016)

Review Neurosciences

Neuroimmune Mechanisms in

Gregory B. Potter et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2016)

Review Neurosciences

Treatment for Krabbe's Disease: Finding the Combination

Christina R. Mikulka et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2016)

Review Neurosciences

Substrate Reduction Therapy for Krabbe's Disease

Scott A. Sands et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2016)

Letter Biotechnology & Applied Microbiology

Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV

Jean-Charles Nault et al.

MOLECULAR THERAPY (2016)

Article Multidisciplinary Sciences

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease

Valentina Cappello et al.

SCIENTIFIC REPORTS (2016)

Review Genetics & Heredity

History, genetic, and recent advances on Krabbe disease

Adriana Carol Eleonora Graziano et al.

Article Medicine, Research & Experimental

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy

Randy J. Chandler et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Neurosciences

Mechanism of Neuromuscular Dysfunction in Krabbe Disease

Ludovico Cantuti-Castelvetri et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Genetics & Heredity

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Jean-Charles Nault et al.

NATURE GENETICS (2015)

Review Pediatrics

Krabbe Disease in the Arab World

Hatem Zayed

JOURNAL OF PEDIATRIC GENETICS (2015)

Article Pathology

Innate Immune Activation in the Pathogenesis of a Murine Model of Globoid Cell Leukodystrophy

Eric R. Snook et al.

AMERICAN JOURNAL OF PATHOLOGY (2014)

Article Biochemistry & Molecular Biology

Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy

Annalisa Lattanzi et al.

HUMAN MOLECULAR GENETICS (2014)

Article Cell Biology

Myelination at a glance

Nicolas Snaidero et al.

JOURNAL OF CELL SCIENCE (2014)

Article Clinical Neurology

Aberrant Production of Tenascin-C in Globoid Cell Leukodystrophy Alters Psychosine-Induced Microglial Functions

Kumiko I. Claycomb et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Article Oncology

Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease

Benjamin R. Smith et al.

JOURNAL OF PATHOLOGY (2014)

Article Clinical Neurology

Frontotemporal dementia and its subtypes: a genome-wide association study

Raffaele Ferrari et al.

LANCET NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease

Gregory B. Potter et al.

HUMAN MOLECULAR GENETICS (2013)

Article Endocrinology & Metabolism

Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review

Rabab Debs et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2013)

Article Chemistry, Analytical

Quantification of psychosine in the serum of twitcher mouse by LC-ESI-tandem-MS analysis

Assunta Zanfini et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)

Article Medicine, Research & Experimental

HIV Tat Domain Improves Cross-correction of Human Galactocerebrosidase in a Gene- and Flanking Sequence-dependent Manner

Xing-Li Meng et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2013)

Review Medicine, Research & Experimental

Lifetime risk estimators in epidemiological studies of Krabbe Disease Review and Monte Carlo comparison

Alexander H. Foss et al.

RARE DISEASES (2013)

Article Genetics & Heredity

Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases

Amy L. Barczykowski et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)

Article Biochemistry & Molecular Biology

The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development

Sara Santambrogio et al.

HUMAN MOLECULAR GENETICS (2012)

Article Biotechnology & Applied Microbiology

Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease

Mohammad A. Rafi et al.

MOLECULAR THERAPY (2012)

Article Clinical Neurology

Axonopathy is a compounding factor in the pathogenesis of Krabbe disease

Ludovico Cantuti Castelvetri et al.

ACTA NEUROPATHOLOGICA (2011)

Article Multidisciplinary Sciences

Insights into Krabbe disease from structures of galactocerebrosidase

Janet E. Deane et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Genetics & Heredity

Identification and Characterization of 15 Novel GALC Gene Mutations Causing Krabbe Disease

Barbara Tappino et al.

HUMAN MUTATION (2010)

Review Clinical Neurology

Newborn Screening for Krabbe Disease: the New York State Model

Patricia K. Duffner et al.

PEDIATRIC NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: Implication for Krabbe Disease

Shailendra Giri et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Multidisciplinary Sciences

Dichotomous dopaminergic control of striatal synaptic plasticity

Weixing Shen et al.

SCIENCE (2008)

Article Multidisciplinary Sciences

AAV vector integration sites in mouse hepatocellular carcinoma

Anthony Donsante et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death

S. Giri et al.

JOURNAL OF LIPID RESEARCH (2006)

Article Biochemistry & Molecular Biology

Transgenic rescue of Krabbe disease in the twitcher mouse

R De Gasperi et al.

GENE THERAPY (2004)

Article Biochemistry & Molecular Biology

Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line

E Haq et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Pathology

Globoid cell-like Leukodystrophy in a domestic longhaired cat

CJ Sigurdson et al.

VETERINARY PATHOLOGY (2002)